Postpartum hemorrhage management in 2012: predicting the future.

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Trauma Surgery

Background:

• Postpartum hemorrhage (PPH) management traditionally relied on historical combat transfusion data.
• Recent military data suggest a revised transfusion approach may improve outcomes.

Purpose of the Study:

• To review current evidence and evolving strategies for transfusion therapy in PPH.
• To highlight the importance of early intervention with blood products and adjuncts.

Main Methods:

• Review of recent military combat casualty transfusion data.
• Analysis of observational data on fibrinogen levels, tranexamic acid, and recombinant factor VIIa use.
• Evaluation of point-of-care testing (thromboelastography) and massive transfusion protocols.

Main Results:

• A 1:1:1 ratio of packed red blood cells, fresh frozen plasma, and platelets improves survival and addresses dilutional coagulopathy.
• Low fibrinogen levels at PPH diagnosis correlate with poorer outcomes, suggesting early replacement benefits.
• Tranexamic acid shows promise in reducing PPH severity, with an evolving role in management.
• Recombinant factor VIIa use should be reserved for refractory bleeding.
• Thromboelastography aids in targeted blood product selection.

Conclusions:

• Evidence supports a shift towards a 1:1:1 transfusion ratio in PPH.
• Early fibrinogen and tranexamic acid administration are crucial components of modern PPH management.
• Point-of-care testing and massive transfusion protocols optimize resource use and patient outcomes.